FGF23 and chronic kidney disease: In conclusion, the current study demonstrates that solid-organ transplantation and immunosuppressive medication post-transplantation are associated with changes in osteocytic protein expression, including increased FGF23 and sclerostin expression, that appear to be distinguishable from the effects of CKD alone on altered osteocyte biology.